Nanovation Therapeutics

Gene Therapy

Nanovation Therapeutics is dedicated to developing next-generation delivery systems for gene therapy. Their core research focuses on developing nucleic acid-agonistic lipid nanoparticles (LNPs) to transport material into cells. Their multidisciplinary team is composed of leading experts in lipid chemistry, RNA design, and nucleic acid delivery. Nanovation’s technology provides methods for synthesizing lipids and LNP compositions, as well as modifying mRNA. They use novel mRNA caps to increase translation and surface-modify lipids to improve tolerability. An expansive library of lipids and formulations are at their disposal to customize any LNP system. Nanovation’s research aims to advance gene therapies by overcoming delivery challenges in the treatment of a wide array of diseases.